BC
Boone Capital Management LLC
Sector-focusedMomentum followerQuality / disciplined sizing
Total reported value
$326.4M
Reporting period: 2026-03-31 · Number of holdings: 13
BOONE CAPITAL MANAGEMENT LLC disclosed 13 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $326.4M and a quarterly turnover rate of 77.8%.
Personality snowflake
- Concentration
- 36.48
- Portfolio Stability
- 77.77
- Momentum/Contrarian
- 100
- Sector conviction
- 100
- Diversification
- 26
- Sizing Uniformity
- 95.51
Recent moves
Add CI
+42.6% $10.1M
Trim MDT
-7.2% -$6.7M
Add BMRN
+33.0% $6.5M
Add MIRM
0.0% $5.6M
Add IONS
+19.8% $4.5M
Trim KOD
-44.2% -$3.4M
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | MIRM | Mirum Pharmaceuticals INC | Stock-Other | 11.92% | +1.48% | — | |
| 2 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 11.51% | +1.14% | +19.79% | |
| 3 | CI | THE Cigna Group | Stock-Healthcare | 11.24% | +2.91% | +42.58% | |
| 4 | MDT | Medtronic plc | Stock-Healthcare | 10.57% | -2.36% | -7.17% | |
| 5 | TFX | Teleflex INC | Stock-Healthcare | 10.22% | +10.22% | NEW | |
| 6 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 9.48% | +1.80% | +33.02% | |
| 7 | GRDN | Guardian Phrmcy Services-a | Stock-Other | 7.28% | +7.28% | NEW | |
| 8 | AZN | AstraZeneca PLC | Stock-Healthcare | 6.65% | +6.65% | NEW | |
| 9 | UNH | Unitedhealth Group INC | Stock-Healthcare | 6.57% | +0.17% | +28.28% | |
| 10 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 5.21% | +0.77% | +23.72% | |
| 11 | AVNS | Avanos Medical INC | Stock-Other | 5.09% | +5.09% | NEW | |
| 12 | KOD | Kodiak Sciences INC | Stock-Other | 3.29% | -1.13% | -44.16% | |
| 13 | TENX | Tenax Therapeutics INC | Stock-Other | 0.98% | +0.98% | NEW |
Reported value over time
Sector allocation
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 13 | $326.4M | 78 | |
| 2025-12-31 | 15 | $318.6M | 49 | |
| 2025-09-30 | 16 | $305.0M | 100 | |
| 2025-06-30 | 11 | $233.2M | 0 | |
| 2025-03-31 | 12 | $293.8M | 0 | |
| 2024-12-31 | 13 | $296.5M | 0 | |
| 2024-09-30 | 17 | $385.8M | 0 | |
| 2024-06-30 | 19 | $383.4M | 0 | |
| 2024-03-31 | 21 | $494.4M | 0 | |
| 2023-12-31 | 21 | $428.4M | 0 | |
| 2023-09-30 | 13 | $317.0M | 0 | |
| 2023-06-30 | 13 | $278.6M | 0 | |
| 2023-03-31 | 12 | $213.6M | 0 | |
| 2022-12-31 | 17 | $194.9M | 0 |
Holding changes this quarter
Boone Capital Management LLC's most significant position changes for 2026-03-31: New buy: Teleflex INC (TFX); New buy: Guardian Phrmcy Services-a (GRDN); New buy: AstraZeneca PLC (AZN); Sold out: Neurocrine Biosciences INC (NBIX); Sold out: Astrazeneca Plc-spons Adr (AZNN).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CI | THE Cigna Group | +2.9% | +42.58% | Add |
| 2 | BMRN | Biomarin Pharmaceutical INC | +1.8% | +33.02% | Add |
| 3 | MIRM | Mirum Pharmaceuticals INC | +1.5% | — | Unchanged |
| 4 | IONS | Ionis Pharmaceuticals INC | +1.1% | +19.79% | Add |
| 5 | BBIO | Bridgebio Pharma INC | +0.8% | +23.72% | Add |
| 6 | UNH | Unitedhealth Group INC | +0.2% | +28.28% | Add |
| 7 | KOD | Kodiak Sciences INC | -1.1% | -44.16% | Trim |
| 8 | MDT | Medtronic plc | -2.4% | -7.17% | Trim |
| 9 | TFX | Teleflex INC | — | NEW | New buy |
| 10 | GRDN | Guardian Phrmcy Services-a | — | NEW | New buy |
| 11 | AZN | AstraZeneca PLC | — | NEW | New buy |
| 12 | NBIX | Neurocrine Biosciences INC | — | EXIT | Sold out |
| 13 | AZNN | Astrazeneca Plc-spons Adr | — | EXIT | Sold out |
| 14 | HQY | Healthequity INC | — | EXIT | Sold out |
| 15 | LIVN | LivaNova PLC | — | EXIT | Sold out |
| 16 | AVNS | Avanos Medical INC | — | NEW | New buy |
| 17 | RAPT | Rapt Therapeutics INC | — | EXIT | Sold out |
| 18 | TYRA | Tyra Biosciences INC | — | EXIT | Sold out |
| 19 | WVE | Wave Life Sciences Ltd. | — | EXIT | Sold out |
| 20 | TENX | Tenax Therapeutics INC | — | NEW | New buy |
FAQ
What is Boone Capital Management LLC and what type of investor is it?
Boone Capital Management LLC is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $326.4M, spread across 13 disclosed positions.
What are Boone Capital Management LLC's largest equity positions?
Based on the latest 13F filing, Boone Capital Management LLC's top holdings by market value are:
1. Mirum Pharmaceuticals INC (MIRM) — $38.9M (11.9%)
2. Ionis Pharmaceuticals INC (IONS) — $37.6M (11.5%)
3. THE Cigna Group (CI) — $36.7M (11.2%)
4. Medtronic plc (MDT) — $34.5M (10.6%)
5. Teleflex INC (TFX) — $33.3M (10.2%)
What changes did Boone Capital Management LLC make in its most recent portfolio filing?
In the latest reported quarter, Boone Capital Management LLC made 19 notable position adjustments: 5 new positions were initiated, 5 existing holdings were added to, 2 positions were partially reduced, and 7 were completely exited. The largest of these moves: New buy: Teleflex INC (TFX); New buy: Guardian Phrmcy Services-a (GRDN); New buy: AstraZeneca PLC (AZN); Sold out: Neurocrine Biosciences INC (NBIX); Sold out: Astrazeneca Plc-spons Adr (AZNN)
What sectors does Boone Capital Management LLC focus on?
Boone Capital Management LLC is concentrated in the following sectors based on its current disclosed equity portfolio:
• Health Care: 100.0%